Common cold symptom reduction through zinc therapy suggested by Cleveland Clinic study.
This article was originally published in The Tan Sheet
Executive Summary
COMMON COLD SYMPTOM REDUCTION THROUGH ZINC LOZENGE THERAPY SUGGESTED by Cleveland Clinic Foundation researchers in a July 15 Annals of Internal Medicine article. Reporting the results of a randomized, placebo-controlled study of 100 subjects, Sherif Mossad, MD, et al. asserted that the duration of cold symptoms was "significantly shorter" for patients receiving zinc-containing lozenges than for those given placebo.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning